<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-id>
      <journal-id journal-id-type="publisher-id">.</journal-id>
      <journal-title>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-title><issn pub-type="ppub">2621-4814</issn><issn pub-type="epub">2621-4814</issn><publisher>
      	<publisher-name>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.33084/bjop.v5i4.3760</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group><subject>COVID-19</subject><subject>Efficacy beliefs</subject><subject>Indonesia</subject><subject>Perceived risk</subject></subj-group>
      </article-categories>
      <title-group>
        <article-title>Illness Risk Perceptions and Efficacy Beliefs Among Indonesian in the Course of COVID-19 Pandemic</article-title><subtitle>Illness Risk Perceptions and Efficacy Beliefs Among Indonesian in the Course of COVID-19 Pandemic</subtitle></title-group>
      <contrib-group><contrib contrib-type="author">
	<name name-style="western">
	<surname>Lolita</surname>
		<given-names>Lolita</given-names>
	</name>
	<aff>Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Ikhsanudin</surname>
		<given-names>Azis</given-names>
	</name>
	<aff>Doctoral Program of Pharmacy, Universitas Gadjah Mada, Sleman, Special Region of Yogyakarta, Indonesia</aff>
	</contrib></contrib-group>		
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>11</month>
        <year>2022</year>
      </pub-date>
      <volume>5</volume>
      <issue>4</issue>
      <permissions>
        <copyright-statement>© 2022 Lolita Lolita, Azis Ikhsanudin</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-sa/4.0/"><p>This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.</p></license>
      </permissions>
      <related-article related-article-type="companion" vol="2" page="e235" id="RA1" ext-link-type="pmc">
			<article-title>Illness Risk Perceptions and Efficacy Beliefs Among Indonesian in the Course of COVID-19 Pandemic</article-title>
      </related-article>
	  <abstract abstract-type="toc">
		<p>
			COVID-19, a worldwide pandemic, has posed a significant challenge to public health systems worldwide. Health risk perception and efficacy belief are primary constructs influencing individuals' protective behavior due to the outbreak. Our study investigated each item of illness risk perception, efficacy belief, and its related factors concerning the COVID-19 pandemic. An analytical cross-sectional study was conducted among 227 respondents aged 17 to 70. Data collection was conducted using convenience sampling by distributing the web questionnaire between April and July 2020. Mann-Whitney or Kruskal-Wallis bivariate analysis was performed using SPSS version 21.0 to assess the relationship between individual characteristic factors, illness risk perception, and efficacy belief. The study established that respondents had a medium to a high level of illness risk perception and a reasonable efficacy belief in dealing with the COVID-19 pandemic. Region (p=0.027) and occupation (p=0.036) differences were significantly associated with the threat and severity perception, respectively. Smoking history (p=0.037), supplement use (p=0.029), and occupation (p=0.018) differences were significantly associated with self-efficacy. Meanwhile, gender (p=0.045) differences were significantly associated with response efficacy. Therefore, the public's illness risk perception and efficacy belief could be substantial in planning, modifying, and implementing a coordinated response for risk communication in current and future epidemics.
		</p>
		</abstract>
    </article-meta>
  </front>
  <body><sec>
			<title>INTRODUCTION</title>
				<p >The novel
coronavirus, SARS-CoV-2, was identified as a cluster cause of atypical cases of
pneumonia in Wuhan, China<bold>1</bold>. World Health Organization (WHO) has declared this coronavirus disease
(COVID-19) a global health emergency due to many confirmed cases in more than
70 countries<bold>2</bold>. Indonesia, the world's fourth most populous country, was reported as
having confirmed two cases of COVID-19 infection on March 2, 2020. The number
of COVID-19 cases remains rapidly increasing in this country<bold>3</bold>. Over the study period, the latest data regarding COVID-19 reported an
increase significantly with an average of over 1790 confirmed cases, with 113
new cases, 170 dead cases, and 112 recovered cases<bold>4</bold>. </p><p >The Indonesian
government has issued several restrictive measures to curtail the spread of the
virus across the nations. However, those policies affect an individual
psychologically, which causes frustration, anxiety, and even the need to change
their daily behavior<bold>5</bold><bold>-</bold><bold>8</bold>. A systematic review<bold>9</bold> reported that this pandemic has led to high mental disorder rates among
the general population. Separate inline, another study<bold>10</bold> has also stated that quarantine measures could worsen a person's
psychological condition, such as depression, anxiety, stress disorder, and
health risk perception.</p><p >Illness risk
perception and efficacy beliefs are reliable predictors of preventive health
behavior<bold>11</bold><bold>,</bold><bold>12</bold>. Illness risk perception is a subjective assessment to respond to fearful
communications about a health threat. It could relate to the efficacy beliefs
as individual capabilities in taking protective action behavior towards a
potential threat<bold>13</bold>. Health behavior theories suggest that perceptions of illness risks relate
to perceptions of vulnerability, severity, and threat<bold>14</bold>. Individuals perceiving significant risks were more likely to implement
protective behaviors. These behaviors are significantly influenced by how much
danger they perceive the event to be, how likely it is to occur, how effective
their current coping behaviors are, and what they believe they can do to solve
the problem<bold>15</bold>. Therefore, monitoring risk perceptions and efficacy beliefs is integral
to public health emergency management. </p><p >The COVID-19
risk perception is considered an essential aspect of health and risk
communication as its goal is to understand what risks of COVID-19 to the public
and how the public addresses them<bold>16</bold>. During the COVID-19 pandemic, the public will have different efficacy
beliefs that will influence how people react to risk<bold>17</bold>. Our previous study<bold>18</bold> found that the perceived risk of acquiring COVID-19 was low when there was
no confirmed case among Indonesian. Meanwhile, the COVID-19 perceived threat
was high at the beginning of outbreaks from March 3 to 27, 2020<bold>19</bold>. People are more considered COVID-19 to be a life-threatening danger to
them at that point. Therefore, our study investigated the individual
characteristic factors influencing COVID-19 risk perception and efficacy
beliefs in different outbreak stages when the number of cases increased
significantly. Those factors include sex, gender, region, education level,
occupation, marital status, monthly personal income, income condition, direct
cash assistance, health status, quarantine conditions, chronic illness, smoking
history, and supplement use. In collaborating with the private sector, the
Indonesian government has pursued comprehensive policies such as large-scale
social distancing, work-from-home, region quarantine, self-isolation, face mask
use, and social distancing to prevent the transmission of COVID-19<bold>20</bold>. Hence, understanding risk perception and efficacy belief will give public
health authorities a vital reference for protective behavior among Indonesian.
Furthermore, these results will determine the willingness of the Indonesians
efforts and contribution to handling COVID-19.</p>
			</sec><sec>
			<title>MATERIALS AND METHODS</title>
				<p ><bold>Materials</bold></p><p >The instrument was
designed based on previous SARS research<bold>21</bold>, translated and
modified to Indonesian<bold>19</bold>. Quantitative data
was generated from a questionnaire containing closed-ended questions. The
online questionnaire was distributed via a link to Google Forms: http://bit.Ly/WHOQOLID.</p><p ><bold>Methods</bold></p><p >Study design and
data collection</p><p >The
study has been reviewed for ethical considerations and obtained approval from
Universitas 'Aisyiyah Yogyakarta Research Ethics Committee (No. 1305/KEP-UNISA/IV/2020).
This cross-sectional online survey was conducted from April to July 2020. The
target population was Indonesian active social media users who used specific
platforms such as Facebook, Twitter, WhatsApp, and Instagram. The participants'
eligibility criteria were Indonesian people aged 17 to 70 years old, active
social media users who resided in Indonesia, and could give informed consent.
We classified the participants into several age groups, such as adolescents (17
to 25 years old), adults (26 to 45 years old), elderly (46 to 65 years old),
and geriatric (above 65 years old). Exclusion criteria were those
non-Indonesian residents who did not complete responding to one or more online
survey items. The minimum sample size of 220 participants was selected using
the Survey System Sample Size Calculator (https://www.surveysystem.com/sscalc.htm), an online survey
software package, with 95% confidence and a 5% significance level. This study
was voluntary and anonymous. The individuals' consent was obtained before data
collection.</p><p >Research instrument
and study variable</p><p >Prior to the distribution of the
questionnaires, reliability tests were carried out. The pilot test was
conducted on a total of 30 study participants. The assessing instrument for
risk perception and efficacy belief were reliable. The Cronbach's alpha and the
validity test for risk perceptions were 0.806 and 0.782, while efficacy beliefs
were 0.703 and 0.612.</p><p >The questionnaire comprised two
sections: sociodemographic characteristics and risk perception with efficacy
beliefs. The first section comprised questions on respondent sociodemographic
characteristics: age, sex, region, education level, occupation, marital status,
personal income, income condition, direct cash assistance, health status,
quarantine conditions, history of chronic illness, smoking history, and the use
of supplements. The second section consisted of a question about perceived risk
and efficacy beliefs. Risk perception has three dimensions: perceived threat,
vulnerability, and severity. In comparison, efficacy beliefs are associated
with response efficacy and self-efficacy.</p><p >The measurement of risk perception
is based on the construct of the protection motivation theory (PMT). The
perceived severity assessed the severity of COVID-19 using a 10-point Likert
scale, from 1 (not severe) to 10 (very severe). Meanwhile, the perceived
vulnerability assessed the likelihood of acquiring this disease using a 5-point
Likert scale, from 1 (very unlikely) to 5 (very likely). The questionnaire used
in this study was adapted from a previous study, whereas each perceived
dimension was rated on a different Likert scale. Furthermore, we calculated the
perceived threat as the overall risk perception measure, which was determined
by the formula as follows (the square root of the multiplication of severity/2
and vulnerability). In order to achieve a level of comparability between the
scores, the severity score was initially divided by two. A square root
transformation was performed to normalize the skewed distribution of the new
variable, resulting in a scale ranging from 1 (low) to 5 (high) for measuring
perceived threat 19. The perceived threat rating was on a scale from 1 to 5, with
1 being "low" and 5 being "high". The response efficacy was
assessed by asking participants to respond to how confident they believe others
around them would be in taking practical actions to prevent contracting
COVID-19 using a 4-point Likert scale from 1 (not at all) to 4 (very much).
Additionally, self-efficacy was determined by asking how confident people felt
that they could prevent contracting the disease. The respondents were asked
each question on a rating scale from 1 ("not confident") to 4 (very
confident). Respondents completed a survey concerning these categories.</p><p ><bold>Data analysis</bold></p><p >A descriptive
statistical analysis was used to examine the frequency of data on
socio-demographic characteristics, risk perception, and efficacy belief toward COVID-19.
All the variables were tested for normality using the Kolmogorov-Smirnov test,
and none were normally distributed. Therefore, the Kruskal-Wallis and
Mann-Whitney tests were employed to determine significant differences in the
categorical independent variable (socio-demographics) on the dependent variable
of risk perception (perceived vulnerability, perceived severity, perceived
severity) and efficacy beliefs (response efficacy, self-efficacy). We analyzed
the data using SPSS version 21.0. Values of p less than 0.05 were considered
statistically significant.</p>
			</sec><sec>
			<title>RESULTS AND DISCUSSION</title>
				<p >The study sampled
232 eligible subjects who filled out the questionnaire with a response rate of
94.8%. After excluding five participants with incomplete data, a final sample
of 227 subjects were required in the current study. The majority of
participants who dominated the survey were female (56.8%), adult (60.4%),
living in the western region (74.4%), holding higher degrees in education
(63.9%), and married (67.4%). Overall, 89% of the participants had good health,
59% used supplements, and 4.8% had a prior history of chronic illness.
Regarding income conditions, they still work outside the home daily (36.1%),
whereas 52.0% have decreased income during the pandemic. Only 6.2% of participants
provided direct financial aid from the government. The sociodemographics of the
participant are listed in <bold>Table I</bold>.</p><p ><bold>Tab</bold><bold>le</bold><bold>I</bold><bold>.</bold> Demographic characteristics of
respondents.</p>

<table-wrap><label>Table</label><table>
 <tr>
  <td>
  Variables
  </td>
  
  <td>
  n
  </td>
  
  <td>
  %
  </td>
  
 </tr>
 <tr>
  <td>
  Sex
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Male
  </td>
  
  <td>
  98
  </td>
  
  <td>
  43.2
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Female
  </td>
  
  <td>
  129
  </td>
  
  <td>
  56.8
  </td>
  
 </tr>
 <tr>
  <td>
  Age
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Adolescent (17 to 25 years old)
  </td>
  
  <td>
  50
  </td>
  
  <td>
  22.0
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Adult (26 to 45 years old)
  </td>
  
  <td>
  137
  </td>
  
  <td>
  60.4
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Elderly (46 to 65 years old)
  </td>
  
  <td>
  37
  </td>
  
  <td>
  16.3
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Geriatric (above 65 years old)
  </td>
  
  <td>
  3
  </td>
  
  <td>
  1.3
  </td>
  
 </tr>
 <tr>
  <td>
  Region (Indonesian time
  zone)
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Western Region
  </td>
  
  <td>
  169
  </td>
  
  <td>
  74.4
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Middle Region
  </td>
  
  <td>
  56
  </td>
  
  <td>
  24.7
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Eastern Region
  </td>
  
  <td>
  2
  </td>
  
  <td>
  0.9
  </td>
  
 </tr>
 <tr>
  <td>
  Education
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Primary education
  </td>
  
  <td>
  12
  </td>
  
  <td>
  5.3
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Middle education
  </td>
  
  <td>
  70
  </td>
  
  <td>
  30.8
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Higher education
  </td>
  
  <td>
  145
  </td>
  
  <td>
  63.9
  </td>
  
 </tr>
 <tr>
  <td>
  Occupation
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Student
  </td>
  
  <td>
  33
  </td>
  
  <td>
  14.5
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Private sector employee
  </td>
  
  <td>
  48
  </td>
  
  <td>
  21.1
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Government worker
  </td>
  
  <td>
  37
  </td>
  
  <td>
  16.3
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Entrepreneur
  </td>
  
  <td>
  32
  </td>
  
  <td>
  14.1
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Others
  </td>
  
  <td>
  77
  </td>
  
  <td>
  33.9
  </td>
  
 </tr>
 <tr>
  <td>
  Marital status
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Married
  </td>
  
  <td>
  153
  </td>
  
  <td>
  67.4
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Single
  </td>
  
  <td>
  59
  </td>
  
  <td>
  26.0
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Widow/Widower
  </td>
  
  <td>
  15
  </td>
  
  <td>
  6.6
  </td>
  
 </tr>
 <tr>
  <td>
  Monthly personal income (IDR)
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Low income
  </td>
  
  <td>
  9
  </td>
  
  <td>
  4.0
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Lower-middle income
  </td>
  
  <td>
  56
  </td>
  
  <td>
  247
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Upper-middle income
  </td>
  
  <td>
  92
  </td>
  
  <td>
  40.5
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  High income
  </td>
  
  <td>
  70
  </td>
  
  <td>
  30.8
  </td>
  
 </tr>
 <tr>
  <td>
  Income conditions 
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Decreased income
  </td>
  
  <td>
  118
  </td>
  
  <td>
  52.0
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Increased revenue
  </td>
  
  <td>
  2
  </td>
  
  <td>
  0.9
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  No changes
  </td>
  
  <td>
  101
  </td>
  
  <td>
  44.5
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  No income
  </td>
  
  <td>
  6
  </td>
  
  <td>
  2.6
  </td>
  
 </tr>
 <tr>
  <td>
  Direct cash assistance
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Yes 
  </td>
  
  <td>
  14
  </td>
  
  <td>
  6.2
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  No
  </td>
  
  <td>
  213
  </td>
  
  <td>
  93.8
  </td>
  
 </tr>
 <tr>
  <td>
  Health status
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Healthy
  </td>
  
  <td>
  205
  </td>
  
  <td>
  90.3
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Do not know
  </td>
  
  <td>
  22
  </td>
  
  <td>
  9.7
  </td>
  
 </tr>
 <tr>
  <td>
  Quarantine conditions
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Full time activities at home
  </td>
  
  <td>
  32
  </td>
  
  <td>
  14.1
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Still leaving the house 2-3x a week is not for work
  </td>
  
  <td>
  51
  </td>
  
  <td>
  22.5
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Work outside the home every day
  </td>
  
  <td>
  82
  </td>
  
  <td>
  36.1
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Work outside the home 2-3x a week
  </td>
  
  <td>
  46
  </td>
  
  <td>
  20.3
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  Others
  </td>
  
  <td>
  16
  </td>
  
  <td>
  7.0
  </td>
  
 </tr>
 <tr>
  <td>
  History of chronic illness 
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Yes
  </td>
  
  <td>
  11
  </td>
  
  <td>
  4.8
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  No
  </td>
  
  <td>
  216
  </td>
  
  <td>
  95.2
  </td>
  
 </tr>
 <tr>
  <td>
  Smoking history 
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Yes
  </td>
  
  <td>
  47
  </td>
  
  <td>
  20.7
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  No
  </td>
  
  <td>
  180
  </td>
  
  <td>
  79.3
  </td>
  
 </tr>
 <tr>
  <td>
  Supplements Use
  </td>
  
  
  
  
  
 </tr>
 <tr>
  
  
  <td>
  Yes
  </td>
  
  <td>
  134
  </td>
  
  <td>
  59.0
  </td>
  
 </tr>
 <tr>
  
  
  <td>
  No
  </td>
  
  <td>
  93
  </td>
  
  <td>
  41.0
  </td>
  
 </tr>
</table></table-wrap>

<p ><bold>Table II</bold> revealed a
statistically significant difference between the efficacy responses between men
and women (p = 0.045). Men participants had a significantly higher mean of
response efficacy than women. Therefore, they are more confident in being able
to take action in trying to prevent COVID-19. Moreover, men are physically
stronger and emotionally more stable than women. Thus, they are more willing to
take precautions to reduce their risk of COVID-19<bold>22</bold>. It is also likely
because men have a lower immune system, which can be attributed to their
differences in innate and adaptive immune responses. Sex-specific responses
result from X chromosome inheritance which contains genes associated with high
immunity<bold>23</bold>. Therefore, men
perceived a higher efficacy response to prevent them from contracting COVID-19
during a pandemic. </p><p >This study also
showed a significant difference in perceived threat between regions (p =
0.027). Participants in the western region had a significantly lower mean of a
perceived threat than those in the middle or eastern regions. People living in
the western region perceive that they are less likely to be exposed to the
COVID-19 threat. The highest number of cases in Indonesia is in the western
regions. World Health Organization estimates that as of February 3, 2022, 65.8%
of Indonesia's cumulative confirmed cases have been reported on Java Island. In
contrast, Jakarta has the highest number of confirmed cases per one million,
followed by East Kalimantan, North Kalimantan, the Special Region of
Yogyakarta, and Central Java<bold>24</bold>. The low perception
of threat among people in the Western Region could affect adherence to health
protocols. These regions also have high mobility and population density, where
many business industrial centers are still operating continuously. It will be a
potential cause of the increasing number of confirmed cases in this area. </p><p >Occupation
differences also have a statistically significant relationship with perceived
severity (p = 0.036) and self-efficacy (p = 0.018). Those who work in
government have a significantly higher perceived seriousness than those who
work in the private sector or entrepreneurship. It means that if government
workers suffer from COVID, it will severely threaten them. The potentially
higher risk of severe outcomes for COVID-19 depends on the worker's
characteristics in various occupations<bold>25</bold>. Previous research<bold>26</bold> has also
demonstrated that government employees have the highest risk of serious adverse
outcomes due to COVID-19. Furthermore, our study found that those in the
private sector have a greater sense of self-efficacy than others. Private
companies have stringent rules in issuing their employees' policies regarding
work regulations and health protection due to the COVID-19 pandemic<bold>27</bold>. Therefore, private
sector employees have more ability to defend themselves from the pandemic. </p><p >Our findings also
revealed that smoking history and use of supplements were significantly
correlated with self-efficacy (p = 0.037; p = 0.029, respectively). Non-smokers
have a stronger belief in their capability to counteract the pandemic threat.
Smoking can increase the likelihood of hand-to-mouth transmission of COVID-19.
It can pose a significant threat to the COVID-19 spread since contaminated
fingers and cigarette sticks will contact the smoker's lips<bold>28</bold><bold>,</bold><bold>29</bold>. A clinical study
suggested that ACE2 may be the receptor being used by SARS-CoV-2 to gain entry
into cells<bold>30</bold><bold>,</bold><bold>31</bold>. Meanwhile, cigarette smoke could induce
mucosa, the primary source of ACE2 in the lungs. Smoking also increases ACE2 in
the lungs, thus enhancing the individual's susceptibility to COVID-19<bold>32</bold>. This statement
aligns with a study about tobacco smokers at high risk of developing severe
co-infections due to impaired lung function, cross-infection, and vulnerable
hygiene habits<bold>29</bold>. Furthermore, the
mortality rate among smokers with COVID-19 infection is higher at 38.5% than
non-smokers<bold>33</bold>. </p><p >Our study stated that
people who consume nutritional supplements have significantly greater
self-efficacy than those who do not. It indicates that they have a lower sense
of risk associated with the pandemic threat, as they take supplements
regularly. Regular diet supplementation with vitamins and micronutrients can
enhance the immune system. It is a different approach to preventing the
transmission of COVID-19<bold>34</bold><bold>,</bold><bold>35</bold>. Sahebnasagh et
al.<bold>36</bold> demonstrated that
specific vitamins are vital in innate and adaptive immune responses. Vitamins
A, D, E, C, and B have antioxidant and immunomodulatory properties which
benefit the immune system. A study has shown that taking probiotics, omega-3
fatty acids, multivitamins, or vitamin D supplements can reduce the risk of
positive COVID-19 test results<bold>37</bold>. </p><p >According to our
findings, participants' mean perceived threat and severity score was
(3.28±0.86) and (8.50±2.05), respectively. Furthermore, we identified that most
respondents had moderate to high levels of concern regarding the risks related
to COVID-19. The majority of participants revealed that they were susceptible
to COVID-19. As COVID-19 cases increase significantly in the field, public
concern in Indonesia regarding the severity of the disease and population
vulnerability is also growing<bold>38</bold>.</p><p ><bold>Tab</bold><bold>le</bold><bold>II</bold><bold>.</bold> Illness risk perceptions and
efficacy beliefs toward COVID-19.</p><table-wrap><label>Table</label><table>
 <tr>
  <td>
  Independent variables
  </td>
  
  <td>
  Dependent variables
  </td>
  
 </tr>
 <tr>
  
  <td>
  Perceived vulnerability
  </td>
  
  <td>
  Perceived severity
  </td>
  
  <td>
  Perceived threat
  </td>
  
  <td>
  Response efficacy
  </td>
  
  <td>
  Self
  efficacy
  </td>
  
 </tr>
 <tr>
  
  
  
  <td>
  p
  </td>
  
  
  
  <td>
  p
  </td>
  
  
  
  <td>
  p
  </td>
  
  
  
  <td>
  p
  </td>
  
  
  
  <td>
  p
  </td>
  
 </tr>
 <tr>
  <td>
  Sex
  </td>
  
 </tr>
 <tr>
  <td>
  Male
  </td>
  
  <td>
  2.76+1.09
  </td>
  
  <td>
  0.370
  </td>
  
  <td>
  8.38+2.04
  </td>
  
  <td>
  0.245
  </td>
  
  <td>
  3.30+0.91
  </td>
  
  <td>
  0.675
  </td>
  
  <td>
  3.49+1.03
  </td>
  
  <td>
  0.045*
  </td>
  
  <td>
  4.13+0.74
  </td>
  
  <td>
  0.980
  </td>
  
 </tr>
 <tr>
  <td>
  Female
  </td>
  
  <td>
  2.61+0.99
  </td>
  
  <td>
  8.59+2.06
  </td>
  
  <td>
  3.25+0.82
  </td>
  
  <td>
  3.22+1.01
  </td>
  
  <td>
  4.13+0.73
  </td>
  
 </tr>
 <tr>
  <td>
  Age
  </td>
  
 </tr>
 <tr>
  <td>
  Adolescent
  </td>
  
  <td>
  2.60±1.09
  </td>
  
  <td>
  0.228
  </td>
  
  <td>
  8.76+1.51
  </td>
  
  <td>
  0.605
  </td>
  
  <td>
  3.29+0.80
  </td>
  
  <td>
  0.203
  </td>
  
  <td>
  3.20+1.16
  </td>
  
  <td>
  0.848
  </td>
  
  <td>
  4.16+0.62
  </td>
  
  <td>
  0.283
  </td>
  
 </tr>
 <tr>
  <td>
  Adult
  </td>
  
  <td>
  2.74±0.98
  </td>
  
  <td>
  8.42+2.27
  </td>
  
  <td>
  3.30+0.87
  </td>
  
  <td>
  3.36+0.95
  </td>
  
  <td>
  4.08+0.79
  </td>
  
 </tr>
 <tr>
  <td>
  Elderly
  </td>
  
  <td>
  2.49±1.17
  </td>
  
  <td>
  8.38+1.85
  </td>
  
  <td>
  3.13+0.93
  </td>
  
  <td>
  3.46+1.12
  </td>
  
  <td>
  4.30+0.62
  </td>
  
 </tr>
 <tr>
  <td>
  Geriatric
  </td>
  
  <td>
  3.00±1.00
  </td>
  
  <td>
  9.00+1.73
  </td>
  
  <td>
  3.62+0.73
  </td>
  
  <td>
  3.00+1.00
  </td>
  
  <td>
  4.00+1.00
  </td>
  
 </tr>
 <tr>
  <td>
  Region
  </td>
  
 </tr>
 <tr>
  <td>
  Western
  Region
  </td>
  
  <td>
  2.60+1.00
  </td>
  
  <td>
  0.063
  </td>
  
  <td>
  8.38+2.16
  </td>
  
  <td>
  0.328
  </td>
  
  <td>
  3.20+0.85
  </td>
  
  <td>
  0.027*
  </td>
  
  <td>
  3.26+0.02
  </td>
  
  <td>
  0.092
  </td>
  
  <td>
  0.41+0.72
  </td>
  
  <td>
  0.697
  </td>
  
 </tr>
 <tr>
  <td>
  Middle
  Region
  </td>
  
  <td>
  2.86+1.10
  </td>
  
  <td>
  8.79+1.67
  </td>
  
  <td>
  3.59+1.00
  </td>
  
  <td>
  3.59+1.00
  </td>
  
  <td>
  0.42+0.70
  </td>
  
 </tr>
 <tr>
  <td>
  Eastern
  Region
  </td>
  
  <td>
  4.00+0.00
  </td>
  
  <td>
  10.0+0.00
  </td>
  
  <td>
  4.47+0.00
  </td>
  
  <td>
  3.00+1.41
  </td>
  
  <td>
  0.35+2.12
  </td>
  
 </tr>
 <tr>
  <td>
  Education
  </td>
  
 </tr>
 <tr>
  <td>
  Primary
  education
  </td>
  
  <td>
  3.00+1.21
  </td>
  
  <td>
  0.504
  </td>
  
  <td>
  9.00+1.35
  </td>
  
  <td>
  0.121
  </td>
  
  <td>
  3.60+0.92
  </td>
  
  <td>
  0.411
  </td>
  
  <td>
  3.33+0.99
  </td>
  
  <td>
  0.855
  </td>
  
  <td>
  4.00+0.74
  </td>
  
  <td>
  0.09
  </td>
  
 </tr>
 <tr>
  <td>
  Middle
  education
  </td>
  
  <td>
  2.64+1.04
  </td>
  
  <td>
  8.96+1.44
  </td>
  
  <td>
  3.35+0.74
  </td>
  
  <td>
  3.44+1.06
  </td>
  
  <td>
  4.13+0.74
  </td>
  
 </tr>
 <tr>
  <td>
  Higher
  education
  </td>
  
  <td>
  2.66+1.02
  </td>
  
  <td>
  8.23+2.29
  </td>
  
  <td>
  3.21+0.90
  </td>
  
  <td>
  3.29+1.01
  </td>
  
  <td>
  4.14+0.73
  </td>
  
 </tr>
 <tr>
  <td>
  Occupation
  </td>
  
 </tr>
 <tr>
  <td>
  Student
  </td>
  
  <td>
  2.58+1.00
  </td>
  
  <td>
  0.771
  </td>
  
  <td>
  8.85+1.66
  </td>
  
  <td>
  0.036*
  </td>
  
  <td>
  3.29+0.74
  </td>
  
  <td>
  0.952
  </td>
  
  <td>
  3.24+1.17
  </td>
  
  <td>
  0.161
  </td>
  
  <td>
  4.15+0.57
  </td>
  
  <td>
  0.018*
  </td>
  
 </tr>
 <tr>
  <td>
  Private
  sector employee
  </td>
  
  <td>
  2.73+1.09
  </td>
  
  <td>
  8.52+2.12
  </td>
  
  <td>
  3.31+0.94
  </td>
  
  <td>
  3.52+1.03
  </td>
  
  <td>
  4.29+0.74
  </td>
  
 </tr>
 <tr>
  <td>
  Government
  worker
  </td>
  
  <td>
  2.84+1.01
  </td>
  
  <td>
  7.68+2.40
  </td>
  
  <td>
  3.19+0.87
  </td>
  
  <td>
  3.22+1.00
  </td>
  
  <td>
  3.78+0.82
  </td>
  
 </tr>
 <tr>
  <td>
  Entrepreneur
  </td>
  
  <td>
  2.53+1.05
  </td>
  
  <td>
  9.19+1.23
  </td>
  
  <td>
  3.31+0.75
  </td>
  
  <td>
  3.63+1.16
  </td>
  
  <td>
  4.28+0.77
  </td>
  
 </tr>
 <tr>
  <td>
  Marital
  status
  </td>
  
 </tr>
 <tr>
  <td>
  Married
  </td>
  
  <td>
  2.73+1.01
  </td>
  
  <td>
  0.297
  </td>
  
  <td>
  8.46+2.19
  </td>
  
  <td>
  0.881
  </td>
  
  <td>
  3.31+0.88
  </td>
  
  <td>
  0.135
  </td>
  
  <td>
  3.39+0.99
  </td>
  
  <td>
  0.139
  </td>
  
  <td>
  4.12+0.74
  </td>
  
  <td>
  0.734
  </td>
  
 </tr>
 <tr>
  <td>
  Single
  </td>
  
  <td>
  2.63+1.07
  </td>
  
  <td>
  8.66+1.66
  </td>
  
  <td>
  3.29+0.81
  </td>
  
  <td>
  3.15+1.06
  </td>
  
  <td>
  4.14+0.68
  </td>
  
 </tr>
 <tr>
  <td>
  Widow/
  Widower
  </td>
  
  <td>
  2.27+1.10
  </td>
  
  <td>
  8.66+1.66
  </td>
  
  <td>
  3.29+0.81
  </td>
  
  <td>
  3.53+1.12
  </td>
  
  <td>
  4.27+0.80
  </td>
  
 </tr>
 <tr>
  <td>
  Monthly
  personal income (IDR)
  </td>
  
 </tr>
 <tr>
  <td>
  Low
  income
  </td>
  
  <td>
  3.00+1.41
  </td>
  
  <td>
  0.547
  </td>
  
  <td>
  8.56+2.24
  </td>
  
  <td>
  0.215
  </td>
  
  <td>
  3.48+1.08
  </td>
  
  <td>
  0.690
  </td>
  
  <td>
  3.11+1.36
  </td>
  
  <td>
  0.691
  </td>
  
  <td>
  4.33+0.71
  </td>
  
  <td>
  0.539
  </td>
  
 </tr>
 <tr>
  <td>
  Lower-middle
  income
  </td>
  
  <td>
  2.70+1.04
  </td>
  
  <td>
  8.52+2.05
  </td>
  
  <td>
  3.31+0.90
  </td>
  
  <td>
  3.50+1.03
  </td>
  
  <td>
  4.09+0.64
  </td>
  
 </tr>
 <tr>
  <td>
  Upper-middle
  income
  </td>
  
  <td>
  2.54+0.92
  </td>
  
  <td>
  8.59+2.03
  </td>
  
  <td>
  3.22+0.78
  </td>
  
  <td>
  3.30+1.04
  </td>
  
  <td>
  4.21+0.73
  </td>
  
 </tr>
 <tr>
  <td>
  High
  income
  </td>
  
  <td>
  2.79+1.11
  </td>
  
  <td>
  8.36+2.09
  </td>
  
  <td>
  3.29+0.90
  </td>
  
  <td>
  3.29+0.97
  </td>
  
  <td>
  4.04+0.79
  </td>
  
 </tr>
 <tr>
  <td>
  Income
  conditions
  </td>
  
 </tr>
 <tr>
  <td>
  Decreased
  income
  </td>
  
  <td>
  2.67+1.01
  </td>
  
  <td>
  0.319
  </td>
  
  <td>
  8.62+2.01
  </td>
  
  <td>
  0.490
  </td>
  
  <td>
  3.30+0.84
  </td>
  
  <td>
  0.064
  </td>
  
  <td>
  3.31+1.04
  </td>
  
  <td>
  0.622
  </td>
  
  <td>
  4.16+0.74
  </td>
  
  <td>
  0.415
  </td>
  
 </tr>
 <tr>
  <td>
  Increased
  revenue
  </td>
  
  <td>
  3.50+0.71
  </td>
  
  <td>
  9.00+1.41
  </td>
  
  <td>
  3.96+0.71
  </td>
  
  <td>
  4.00+0.00
  </td>
  
  <td>
  4.00+0.00
  </td>
  
 </tr>
 <tr>
  <td>
  No
  changes
  </td>
  
  <td>
  2.69+1.03
  </td>
  
  <td>
  8.45+1.94
  </td>
  
  <td>
  3.28+0.83
  </td>
  
  <td>
  3.35+1.00
  </td>
  
  <td>
  4.08+0.72
  </td>
  
 </tr>
 <tr>
  <td>
  No income
  </td>
  
  <td>
  2.17+1.60
  </td>
  
  <td>
  6.83+3.97
  </td>
  
  <td>
  2.38+1.34
  </td>
  
  <td>
  3.67+1.21
  </td>
  
  <td>
  4.50+0.84
  </td>
  
 </tr>
 <tr>
  <td>
  Direct
  cash assistance
  </td>
  
 </tr>
 <tr>
  <td>
  Yes
  </td>
  
  <td>
  2.71+1.27
  </td>
  
  <td>
  0.884
  </td>
  
  <td>
  8.57+1.83
  </td>
  
  <td>
  0.966
  </td>
  
  <td>
  3.29+0.95
  </td>
  
  <td>
  0.988
  </td>
  
  <td>
  2.93+0.92
  </td>
  
  <td>
  0.101
  </td>
  
  <td>
  4.00+0.68
  </td>
  
  <td>
  0.416
  </td>
  
 </tr>
 <tr>
  <td>
  No
  </td>
  
  <td>
  2.67+1.02
  </td>
  
  <td>
  8.50+2.07
  </td>
  
  <td>
  3.28+0.86
  </td>
  
  <td>
  3.36+1.03
  </td>
  
  <td>
  4.14+0.73
  </td>
  
 </tr>
 <tr>
  <td>
  Health
  status
  </td>
  
 </tr>
 <tr>
  <td>
  Healthy
  </td>
  
  <td>
  2.62+1.02
  </td>
  
  <td>
  0.028
  </td>
  
  <td>
  8.47+2.09
  </td>
  
  <td>
  0.955
  </td>
  
  <td>
  3.23+0.85
  </td>
  
  <td>
  0.050
  </td>
  
  <td>
  3.37+1.03
  </td>
  
  <td>
  0.269
  </td>
  
  <td>
  4.17+0.74
  </td>
  
  <td>
  0.029
  </td>
  
 </tr>
 <tr>
  <td>
  Do
  not know
  </td>
  
  <td>
  3.19+1.08
  </td>
  
  <td>
  8.67+1.71
  </td>
  
  <td>
  3.68+0.91
  </td>
  
  <td>
  3.10+0.99
  </td>
  
  <td>
  3.81+0.60
  </td>
  
 </tr>
 <tr>
  <td>
  Quarantine
  conditions
  </td>
  
 </tr>
 <tr>
  <td>
  Full
  time activities at home
  </td>
  
  <td>
  2.56+1.19
  </td>
  
  <td>
  0.052
  </td>
  
  <td>
  8.38+2.03
  </td>
  
  <td>
  0.559
  </td>
  
  <td>
  3.19+0.97
  </td>
  
  <td>
  0.087
  </td>
  
  <td>
  3.44+1.16
  </td>
  
  <td>
  0.464
  </td>
  
  <td>
  4.28+0.68
  </td>
  
  <td>
  0.567
  </td>
  
 </tr>
 <tr>
  <td>
  Leaving
  the house 2-3x per week not for work
  </td>
  
  <td>
  2.65+0.87
  </td>
  
  <td>
  8.86+1.71
  </td>
  
  <td>
  3.35+0.68
  </td>
  
  <td>
  3.16+0.93
  </td>
  
  <td>
  4.16+0.67
  </td>
  
 </tr>
 <tr>
  <td>
  Work
  outside every day
  </td>
  
  <td>
  2.94+1.13
  </td>
  
  <td>
  8.44+2.14
  </td>
  
  <td>
  3.43+0.95
  </td>
  
  <td>
  3.39+1.03
  </td>
  
  <td>
  4.12+0.79
  </td>
  
 </tr>
 <tr>
  <td>
  Work
  outside 2-3x per week
  </td>
  
  <td>
  2.35+0.85
  </td>
  
  <td>
  8.54+1.92
  </td>
  
  <td>
  3.08+0.71
  </td>
  
  <td>
  3.43+1.00
  </td>
  
  <td>
  4.09+0.73
  </td>
  
 </tr>
 <tr>
  <td>
  Others
  </td>
  
  <td>
  2.56+0.97
  </td>
  
  <td>
  7.75+2.84
  </td>
  
  <td>
  3.00+0.96
  </td>
  
  <td>
  3.19+1.11
  </td>
  
  <td>
  3.94+0.68
  </td>
  
 </tr>
 <tr>
  <td>
  History
  of chronic illness
  </td>
  
 </tr>
 <tr>
  <td>
  Yes
  </td>
  
  <td>
  2.55+0.82
  </td>
  
  <td>
  0.779
  </td>
  
  <td>
  9.00+1.55
  </td>
  
  <td>
  0.479
  </td>
  
  <td>
  3.35+0.74
  </td>
  
  <td>
  0.585
  </td>
  
  <td>
  2.91+0.83
  </td>
  
  <td>
  0.204
  </td>
  
  <td>
  4.18+0.75
  </td>
  
  <td>
  0.835
  </td>
  
 </tr>
 <tr>
  <td>
  No
  </td>
  
  <td>
  2.68+1.05
  </td>
  
  <td>
  8.47+2.07
  </td>
  
  <td>
  3.27+0.87
  </td>
  
  <td>
  3.36+1.03
  </td>
  
  <td>
  4.13+0.73
  </td>
  
 </tr>
 <tr>
  <td>
  Smoking
  history
  </td>
  
 </tr>
 <tr>
  <td>
  Yes
  </td>
  
  <td>
  2.89+1.05
  </td>
  
  <td>
  0.114
  </td>
  
  <td>
  8.45+1.82
  </td>
  
  <td>
  0.403
  </td>
  
  <td>
  3.43+0.87
  </td>
  
  <td>
  0.173
  </td>
  
  <td>
  3.47+1.04
  </td>
  
  <td>
  0.358
  </td>
  
  <td>
  3.94+0.73
  </td>
  
  <td>
  0.037*
  </td>
  
 </tr>
 <tr>
  <td>
  No
  </td>
  
  <td>
  2.62+1.03
  </td>
  
  <td>
  8.51+2.11
  </td>
  
  <td>
  3.23+0.85
  </td>
  
  <td>
  3.31+1.02
  </td>
  
  <td>
  4.18+0.72
  </td>
  
 </tr>
 <tr>
  <td>
  Supplement
  use
  </td>
  
 </tr>
 <tr>
  <td>
  Yes
  </td>
  
  <td>
  2.69+1.07
  </td>
  
  <td>
  0.800
  </td>
  
  <td>
  8.50+2.25
  </td>
  
  <td>
  0.183
  </td>
  
  <td>
  3.26+0.90
  </td>
  
  <td>
  0.828
  </td>
  
  <td>
  3.28+1.07
  </td>
  
  <td>
  0.334
  </td>
  
  <td>
  4.22+0.74
  </td>
  
  <td>
  0.029*
  </td>
  
 </tr>
 <tr>
  <td>
  No
  </td>
  
  <td>
  2.66+0.98
  </td>
  
  <td>
  8.49+1.74
  </td>
  
  <td>
  3.29+0.80
  </td>
  
  <td>
  3.42+0.96
  </td>
  
  <td>
  4.01+0.70
  </td>
  
 </tr>
</table></table-wrap><p >Note: * Significantly different</p><p ><bold>Table II</bold> reported that
respondents' mean score of perceived severity was male (8.38±2.04) and female
(8.59±2.06). This high score indicated that the perceived severity of COVID-19
among males and females was severe and fatal. The general population's severity
perception in Indonesia is higher than in the Myanmar-based study<bold>39</bold>. Similar results
were found in a study in Hongkong<bold>40</bold>, in which all
participants agreed that the COVID-19 disease was very severe. Regarding the
pandemic, the internet and other information sources can better influence
people's thinking in applying protective measures<bold>41</bold>. A study reported
that respondents in Indonesia had taken more protective behavior. People who
often get information related to COVID will have firmer self-efficacy beliefs<bold>42</bold>. Mya et al.<bold>39</bold> have reported that
individuals would engage in more protective behavior due to easy access to mass
media and social media. </p><p >A person perceiving
the high risk of COVID-19 is likely to feel stress, panic, depression, and try
to adapt to others' behavior. It is because strong negative emotions could
encourage one to think about protective behavior in the face of this pandemic<bold>43</bold>. Nevertheless, the
higher threat perceived by vulnerable groups may increase their self-protective
behavior, which is beneficial in pandemic control. However, those with a
low-risk perception of COVID-19 are less likely to engage in protective
behavior. Thus, public health education is targeted at this group<bold>44</bold>. </p><p >Understanding risk
perception is a complex phenomenon created from various psychological, social,
and cultural factors in different places and times. This phenomenon can be
interpreted as a form of pandemic preparedness. Based on previous studies, risk
perception can assess and evaluate an individual's response to a pandemic<bold>45</bold>. Though perceived
risk acts as a trigger for preventive actions, it is also determined by a
person's social networks, community beliefs, and the source of information
about health behavior<bold>46</bold>. Social networks
may amplify the spread of beneficial or dangerous behavior during this COVID-19
pandemic<bold>47</bold>. As a non-medical
measure, personal protective practices are needed to control the COVID-19
pandemic by implementing health protocols, wearing masks, avoiding crowds, and
maintaining social distancing. The community's willingness could play a vital
role in successfully implementing government policies<bold>48</bold>.</p>
			</sec><sec>
			<title>CONCLUSION</title>
				<p >We
concluded a moderate to high level of risk perceptions associated with COVID-19
in Indonesia's general population. Additionally, they had a relatively good
efficacy response in adopting self-protection measures during the COVID-19
pandemic. The public's risk perception of a pandemic contributes to increasing
participation in preventing the COVID-19 pandemic. Furthermore, these findings
will contribute to the health authorities regarding COVID-19 pandemic risk
communication management.</p>
			</sec><sec>
			<title>ACKNOWLEDGMENT</title>
				<p >We are grateful to all
participants who gave their time to this research. The authors received no
financial support for this study, authorship, or publication.</p>
			</sec><sec>
			<title>AUTHORS’ CONTRIBUTION</title>
				<p ><bold>Lolita</bold>: study design, methodology, data collection, validation, and
writing–original draft. <bold>Azis Ikhsanudin</bold>: data management, data
collection, visualization, statistical analysis, and editing.</p>
			</sec><sec>
			<title>DATA AVAILABILITY</title>
				<p >None.</p>
			</sec><sec>
			<title>CONFLICT OF INTEREST</title>
				<p >The
authors declare no conflict of interest.</p>
			</sec><sec>
			<title>REFERENCES</title>
				<p >1. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019
novel coronavirus of pneumonia in Wuhan, China: emerging attack and management
strategies. Clin Transl Med. 2020;9(1):19. doi:10.1186/s40169-020-00271-z</p><p >2. Cucinotta D, Vanelli M. WHO Declares COVID-19 a
Pandemic. Acta Biomed. 2020;91(1):157-60. doi:10.23750/abm.v91i1.9397</p><p >3. Djalante R, Lassa J, Setiamarga D, Sudjatma A,
Indrawan M, Haryanto B, et al. Review and analysis of current responses to
COVID-19 in Indonesia: Period of January to March 2020. Prog Disaster Sci.
2020;6:100091. doi:10.1016/j.pdisas.2020.100091</p><p >4. World Health Organization. Coronavirus Disease
2019 (COVID-19) Situation Report-18. Jakarta, Indonesia: WHO Indonesia; 2020. Available
from: https://www.who.int/docs/default-source/searo/indonesia/covid19/who-situation-report-18.pdf</p><p >5. Alam MM, Fawzi AM, Islam MM, Said J. Impacts of
COVID-19 pandemic on national security issues: Indonesia as a case study. Secur
J. 2022;35(4):1067-86. doi:10.1057/s41284-021-00314-1</p><p >6.
Lusida MAP, Salamah S, Jonatan M, Wiyogo IO, Asyari CH, Ali ND, et al. Prevalence
of and risk factors for depression, anxiety, and stress in non-hospitalized
asymptomatic and mild COVID-19 patients in East Java province, Indonesia. PLoS
One. 2022;17(7):e0270966. doi:10.1371/journal.pone.0270966</p><p >7.
Akbar Z, Aisyawati MS. Coping Strategy, Social Support, and
Psychological Distress Among University Students in Jakarta, Indonesia During
the COVID-19 Pandemic. Front Psychol. 2021;12:694122. doi:10.3389/fpsyg.2021.694122</p><p >8. Abdullah I. COVID-19: Threat and fear in
Indonesia. Psychol Trauma Theory Res Pract Policy. 2021;12(5):488-90. doi:10.1037/tra0000878</p><p >9. Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H,
Phan L, et al. Impact of COVID-19 pandemic on mental health in the general
population: A systematic review. J
Affect Disord. 2020;277:55–64. doi:10.1016/j.jad.2020.08.001</p><p >10. Giallonardo V, Sampogna G, Del Vecchio V,
Luciano M, Albert U, Carmassi C, et al. The Impact of Quarantine and Physical
Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric
Italian Population Trial. Front psychiatry. 2020;11:533. doi:10.3389/fpsyt.2020.00533</p><p >11. Zewdie A, Mose A, Sahle T, Bedewi J, Gashu M,
Kebede N, et al. The health belief model's ability to predict COVID-19
preventive behavior: A systematic review. SAGE Open Med. 2022;10:20503121221113668.
doi:10.1177/20503121221113668</p><p >12. Karl JA, Fischer R, Druică E, Musso F, Stan A. Testing
the Effectiveness of the Health Belief Model in Predicting Preventive Behavior
During the COVID-19 Pandemic: The Case of Romania and Italy. Front Psychol.
2022;12:627575. doi:10.3389/fpsyg.2021.627575</p><p >13. Sobkow A, Zaleskiewicz T, Petrova D,
Garcia-Retamero R, Traczyk J. Worry, Risk Perception, and Controllability
Predict Intentions Toward COVID-19 Preventive Behaviors. Front Psychol.
2020;11:582720. doi:10.3389/fpsyg.2020.582720</p><p >14. Ferrer R, Klein WM. Risk perceptions and health
behavior. Curr Opin Psychol. 2015;5:85-9. doi:10.1016/j.copsyc.2015.03.012</p><p >15. Schneiderman N, Ironson G, Siegel SD. Stress and
health: psychological, behavioral, and biological determinants. Annu Rev Clin
Psychol. 2005;1:607-28. doi:10.1146/annurev.clinpsy.1.102803.144141</p><p >16. Cipolletta S, Andreghetti GR, Mioni G. Risk
Perception towards COVID-19: A Systematic Review and Qualitative Synthesis. Int
J Environ Res Public Health. 2022;19(8):4649. doi:10.3390/ijerph19084649</p><p >17. Diotaiuti P, Valente G, Mancone S, Falese L,
Bellizzi F, Anastasi D, et al. Perception of Risk, Self-Efficacy and Social
Trust during the Diffusion of Covid-19 in Italy. Int J Environ Res Public
Health. 2021;18(7):3427. doi:10.3390/ijerph18073427</p><p >18. Nanda RO, Lolita L, Indayati W, Rusdiyanti I,
Ikhsanudin A, Mareti S. Knowledge, precautionary actions, and perceived risk of
COVID-19 among indonesian people. Int J Public Health Sci. 2021;10(1):8–15.
doi:10.11591/ijphs.v10i1.20589</p><p >19. Nanda RO, Lolita L, Indayati W, Rusdiyanti I,
Nurjannah, Ikhsanudin A, et al. Covid-19 risk perception among Indonesians in
early stage of the outbreak. Int J Public Health Sci. 2021;10(2):249–57. doi:10.11591/ijphs.v10i2.20678</p><p >20. Lutfi M, Buntuang PCD, Kornelius Y, Erdiyansyah,
Hasanuddin B. The impact of social distancing policy on small and medium-sized
enterprises (SMEs) in Indonesia. Probl Perspect Manag. 2020;18(3):492-503. doi:10.21511/ppm.18(3).2020.40</p><p >21. de Zwart O, Veldhuijzen IK, Elam G, Aro AR,
Abraham T, Bishop GD, et al. Perceived threat, risk perception, and efficacy
beliefs related to SARS and other (emerging) infectious diseases: Results of an
international survey. Int J Behav Med. 2009;16(1):30–40. doi:10.1007/s12529-008-9008-2</p><p >22. Umamaheswar J, Tan C. “Dad, Wash Your Hands”:
Gender, Care Work, and Attitudes toward Risk during the COVID-19 Pandemic.
Socius. 2020;6:1-14. doi:10.1177/2378023120964376</p><p >23. Griffith DM, Sharma G, Holliday CS, Enyia OK,
Valliere M, Semlow AR, et al. Men and COVID-19: A Biopsychosocial Approach to
Understanding Sex Differences in Mortality and Recommendations for Practice and
Policy Interventions. Prev Chronic Dis. 2020;17:E63. doi:10.5888/pcd17.200247</p><p >24. World Health Organization. Coronavirus Disease
2019 (COVID-19) Situation Report-41. Jakarta, Indonesia: WHO Indonesia; 2020. Available
from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf?sfvrsn=6768306d_2&amp;download=true</p><p >25. van der Plaat DA, Madan I, Coggon D, van Tongeren
M, Edge R, Muiry R, et al. Risks of COVID-19 by occupation in NHS workers in
England. Occup Environ Med. 2022;79(3):176-83. doi:10.1136/oemed-2021-107628</p><p >26. Walsh B, Redmond P, Roantree B, Redmond P.
Differences in risk of severe outcomes from COVID-19 across occupations in
Ireland. ESRI Survey and Statistical Report Series Number 93. Dublin, Ireland: The
Economic and Social Research Institute; 2020. doi:10.26504/sustat93</p><p >27. Lan FY, Wei CF, Hsu YT, Christiani DC, Kales SN.
Work-related COVID-19 transmission in six Asian countries/areas: A follow-up
study. PLoS One. 2020;15(5):e0233588. doi:10.1371/journal.pone.0233588</p><p >28. Kashyap VK, Dhasmana A, Massey A, Kotnala S,
Zafar N, Jaggi M, et al. Smoking and COVID-19: Adding Fuel to the Flame. Int J
Mol Sci. 2020;21(18):6581. doi:10.3390/ijms21186581</p><p >29. Ahmed N, Maqsood A, Abduljabbar T, Vohra F. Tobacco
Smoking a Potential Risk Factor in Transmission of COVID-19 Infection. Pak J
Med Sci. 2020;36(COVID19-S4):S104-7. doi:10.12669/pjms.36.covid19-s4.2739</p><p >30. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK,
Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for
the SARS coronavirus. Nature. 2003;426(6965):450-4. doi:10.1038/nature02145</p><p >31. Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et
al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care.
2020;24(1):422. doi:10.1186/s13054-020-03120-0</p><p >32. Polverino F. Cigarette Smoking and COVID-19: A
Complex Interaction. Am J Respir Crit Care Med. 2020;202(3):471–2. doi:10.1164/rccm.202005-1646le </p><p >33. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi
SM, Almehmadi M, Alqahtani AS, et al. Prevalence, Severity and Mortality
associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic
Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147 </p><p >34. Kumar P, Kumar M, Bedi O, Gupta M, Kumar S,
Jaiswal G, et al. Role of vitamins and minerals as immunity boosters in
COVID-19. Inflammopharmacology. 2021;29(4):1001-16. doi:10.1007/s10787-021-00826-7 </p><p >35. Ahmed MH, Hassan A, Molnár J. The Role of
Micronutrients to Support Immunity for COVID-19 Prevention. Rev Bras Farmacogn.
2021;31(4):361-74. doi:10.1007/s43450-021-00179-w </p><p >36. Sahebnasagh A, Saghafi F, Avan R, Khoshi A,
Khataminia M, Safdari M, et al. The prophylaxis and treatment potential of
supplements for COVID-19. Eur J Pharmacol. 2020;887:173530. doi:10.1016/j.ejphar.2020.173530</p><p >37. Mrityunjaya M, Pavithra V, Neelam R, Janhavi P,
Halami PM, Ravindra PV. Immune-Boosting, Antioxidant and Anti-inflammatory Food
Supplements Targeting Pathogenesis of COVID-19. Front Immunol. 2020;11:570122.
doi:10.3389/fimmu.2020.570122</p><p >38. Handayani W, Insani TD, Fisher M, Gim THT,
Mardhotillah S, Adam UEF. Effects of COVID-19 restriction measures in
Indonesia: A comparative spatial and policy analysis of selected urban
agglomerations. Int J Disaster Risk Reduct. 2022;76:103015. doi:10.1016/j.ijdrr.2022.103015</p><p >39. Mya KS, Aye SM, Hlaing WA, Hlaing SS, Aung T,
Lwin SMM, et al. Awareness, perceived risk and protective behaviours of Myanmar
adults on COVID-19. Int J Commun Med Public Health. 2020;7(5):1627. doi:10.18203/2394-6040.ijcmph20201530</p><p >40. Kwok KO, Li KK, Chan HHH, Yi YY, Tang A, Wei WI,
et al. Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong.
Emerg Infect Dis. 2020;26(7):1575–9. doi:10.3201/eid2607.200500</p><p >41. Yıldırım M, Güler A. COVID-19 severity,
self-efficacy, knowledge, preventive behaviors, and mental health in Turkey.
Death Stud. 2020;46(4):979-86. doi:10.1080/07481187.2020.1793434</p><p >42. Sulistyawati, Rokhmayanti, Aji B, Wijayanti SPM,
Hastuti SKW, Sukesi TW, et al. Knowledge, Attitudes, Practices and Information
Needs During the COVID-19 Pandemic in Indonesia. Risk Manag Healthc Policy.
2021;14:163. doi:10.2147/rmhp.s288579</p><p >43. Serafini G, Parmiagini B, Amerio A, Aguglia A,
Sher L, Amore M. The psychological impact of COVID-19 on the mental health in
the general population. QJM. 2020;113(8):531-7. doi:10.1093/qjmed/hcaa201</p><p >44. Husnah, Salawati L, Sakdiah, Nazira N, Firdausa
S, Nawawi YS. Perception and preventive behavior during COVID-19 pandemic among
residents in Banda Aceh, Indonesia: a cross-sectional study. Med J Indones.
2021;30:290-6. doi:10.13181/mji.oa.215674</p><p >45. Cori L, Bianchi F, Cadum E, Anthonj C. Risk
Perception and COVID-19. Int J Environ Res Public Health. 2020;17(9):3114. doi:10.3390/ijerph17093114</p><p >46. Ghio D, Lawes-Wickwar S, Tang MY, Epton T,
Howlett N, Jenkinson E, et al. What influences people's responses to public
health messages for managing risks and preventing infectious diseases? A rapid
systematic review of the evidence and recommendations. BMJ Open.
2021;11(11):e048750. doi:10.1136/bmjopen-2021-048750</p><p >47. Liu PL. COVID-19 information on social media and
preventive behaviors: Managing the pandemic through personal responsibility.
Soc Sci Med. 2021;277:113928. doi:10.1016/j.socscimed.2021.113928</p><p >48. Ayuningtyas D, Haq HU, Utami RRM, Susilia S. Requestioning
the Indonesia Government's Public Policy Response to the COVID-19 Pandemic:
Black Box Analysis for the Period of January-July 2020. Front Public Health.
2021;9:612994. doi:10.3389/fpubh.2021.612994 </p>
			</sec></body>
  <back>
    <ack>
      <p>We are grateful to all participants who gave their time to this research. The authors received no financial support for this study, authorship, or publication.</p>
    </ack>
  </back>
</article>